Dr. PANAGIOTA TSIATSIOU, AHEPA UNIVERSITY HOSPITAL, Greece
Dr. Panagiota Tsiatsiou is a dedicated medical biopathologist with over two decades of service in the Greek National Health System. Born on March 17, 1969, in Thessaloniki, Greece, she earned her M.D. from the Aristotle University of Thessaloniki and has specialized in hematology diagnostics, molecular biology, and public health. Since 2011, she has served in the Hematology Section at AHEPA University Hospital and was appointed Director in 2018. Her role extends beyond diagnostics to include leadership, training of residents, and managing lab operations, especially during the COVID-19 pandemic. With three Master’s degrees and active participation in scientific publications and conferences, Dr. Tsiatsiou continues to bridge clinical practice and research. Her work on angiopoietins and biomarkers in COVID-19 patients demonstrates her commitment to innovative healthcare solutions and translational medicine.
Publication Profile:
Scopus
Orcid
✅ Strengths for the Award:
-
Extensive Clinical and Laboratory Expertise
Over 20 years of experience in microbiology and hematology laboratories, with advanced specialization in Medical Biopathology, PCR techniques, and molecular hematology.
-
Research Impact in COVID-19
Lead author in two recent international peer-reviewed publications (2024, 2025) on angiopoietins and endothelial damage in COVID-19—topics of significant relevance in post-pandemic biomedical research.
-
Academic Qualifications
Holder of three Master’s degrees in Health Services Management, Public Health, and Biomedical Sciences—demonstrating a strong interdisciplinary foundation and commitment to academic excellence.
-
Mentorship and Leadership
Director of the Hematology Section at AHEPA University Hospital since 2018; deeply involved in resident training and lab coordination, especially during the pandemic, proving strong leadership under crisis.
-
Scientific Contribution
-
6 publications (4 international, 2 Greek)
-
99 scientific papers
-
Participation in 158 scientific conferences, workshops, and seminars—highlighting strong engagement with the research community.
⚠️ Areas for Improvement:
-
Global Visibility
While research quality is high, international recognition could be improved by targeting higher-impact journals and expanding collaborations outside Greece.
-
Grants and Funding Leadership
CV does not specify involvement in research grant acquisition or project funding management—which are often critical metrics in high-level research awards.
-
Innovation and Patents
There is no mention of patents, technological innovation, or industry partnerships, which could further enhance her scientific portfolio.
-
Broader Publication Scope
Expanding beyond COVID-19-related studies to publish more widely in hematologic and molecular diagnostics would strengthen her long-term research narrative.
🎓 Education:
Dr. Tsiatsiou holds a solid educational background in medicine and public health. She completed her M.D. at the Aristotle University of Thessaloniki (1988–1995), followed by rural service and specialization in Medical Biopathology at Theageneio Anticancer Hospital, obtaining her board certification in 2002. She pursued a Master’s in Health Services Management (2005–2008) at the Hellenic Open University, focusing on blood donor psychology. She furthered her expertise with a Master’s in Public Health at the National School of Public Health, where she studied foodborne infections. Additionally, she obtained a Master’s in Biomedical Sciences with a concentration in Diagnosis and Therapy, focusing on genetic mutations like FV Leiden. Her academic trajectory reflects a deep interdisciplinary approach—combining clinical knowledge, health systems, and research.
🏥 Experience:
Dr. Tsiatsiou’s clinical career spans more than 20 years, primarily within Greece’s National Health System. From 2003 to 2020, she served in various microbiology labs, refining her diagnostic skills. Since July 2011, she has worked in the Hematology Section at AHEPA University Hospital, leading the unit since 2018. Her expertise includes hemostasis, hemoglobinopathies, and molecular testing, and she has been instrumental in staff training and lab management. She led the hemostasis lab during the COVID-19 pandemic, ensuring continuity and quality of diagnostics under pressure. Her dedication to resident education in both Medical Biopathology and General Medicine has made her a respected mentor. Dr. Tsiatsiou’s leadership has elevated the lab’s scientific output, and her involvement in over 150 conferences showcases her engagement with ongoing medical developments.
🔬 Research Focus:
Dr. Tsiatsiou’s research is centered on hematology diagnostics, hemostasis disorders, and molecular markers in infectious diseases. Her most recent work investigates endothelial damage and angiopoietin levels as predictors in COVID-19 patients during the Delta and Omicron waves. This research bridges laboratory medicine with clinical outcomes, offering vital insights into disease severity and prognostics. She also explores genetic predispositions, such as FV Leiden mutations, in thrombotic risk profiling. Her postgraduate theses and training in PCR and molecular hematology underscore her commitment to translational science. With 6 peer-reviewed publications and 99 scientific papers, her academic output is diverse and impactful. Dr. Tsiatsiou’s multidimensional research contributes not only to hematology but also to public health and epidemiology, making her work highly relevant in modern medicine and worthy of recognition.
📚 Publications Top Notes:
-
📄 Biomarkers of Endothelial Damage and Disease Severity in COVID-19 Patients, Current Issues in Molecular Biology, 2025
-
📄 Angiopoietins as Predictor Indexes in COVID-19 Patients in Delta and Omicron Waves, Current Issues in Molecular Biology, 2024
-
📄 Thesis: Trends, Attitudes, and Motivations of Blood Donors and Non-Donors – Hellenic Open University
-
📄 Thesis: Foodborne Infections in Urban and Rural Populations of Central Macedonia – National School of Public Health
-
📄 Thesis: Prevalence of FV Leiden Mutation in a Tertiary Hospital – Democritus University of Thrace & IHU
-
📄 Additional 99 scientific papers and 158 participations in academic events
🧾 Conclusion:
Dr. Panagiota Tsiatsiou is a highly qualified and impactful researcher with significant contributions in hematology, molecular diagnostics, and public health. Her recent publications in Current Issues in Molecular Biology show scientific depth and relevance, especially regarding the clinical progression of COVID-19. She is an excellent candidate for a national or institutional Best Researcher Award, particularly in medical diagnostics and laboratory medicine.